Evidence map›Paper›PMID 12807766›Full record

ArticleGenetics2003

Delineating the requirements for spontaneous DNA damage resistance pathways in genome maintenance and viability in Saccharomyces cerevisiae.

Natalie J Morey, Paul W Doetsch, Sue Jinks-Robertson

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Natalie J MoreyDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Paul W Doetsch
Sue Jinks-Robertson
Emory University · US

Funding

REGULATION OF MITOTIC RECOMBINATION IN YEASTR01GM038464 · NIGMS · EMORY UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1992 to 2015
$3.6M
TRANSCRIPTIONAL MUTAGENESIS BY IONIZING RADIATIONR01CA078622 · NCI · EMORY UNIVERSITY · PI DOETSCH, PAUL W. · 1998 to 2002
$848k
RECOMBINATION BETWEEN REPEATED SEQUENCE IN YEASTR29GM038464 · NIGMS · EMORY UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1987 to 1991
–
NCI NIH HHS CA-73401NCI NIH HHS CA-78622NIGMS NIH HHS GM-38464
6 · The paper itself

Abstract

Cellular metabolic processes constantly generate reactive species that damage DNA. To counteract this relentless assault, cells have developed multiple pathways to resist damage. The base excision repair (BER) and nucleotide excision repair (NER) pathways remove damage whereas the recombination (REC) and postreplication repair (PRR) pathways bypass the damage, allowing deferred removal. Genetic studies in yeast indicate that these pathways can process a common spontaneous lesion(s), with mutational inactivation of any pathway increasing the burden on the remaining pathways. In this study, we examine the consequences of simultaneously compromising three or more of these pathways. Although the presence of a functional BER pathway alone is able to support haploid growth, retention of the NER, REC, or PRR pathway alone is not, indicating that BER is the key damage resistance pathway in yeast and may be responsible for the removal of the majority of either spontaneous DNA damage or specifically those lesions that are potentially lethal. In the diploid state, functional BER, NER, or REC alone can support growth, while PRR alone is insufficient for growth. In diploids, the presence of PRR alone may confer a lethal mutation load or, alternatively, PRR alone may be insufficient to deal with potentially lethal, replication-blocking lesions.

Indexed as

DNA DamageGenes, FungalGenome, FungalAllelesCell DivisionCell SurvivalDiploidyDNA RepairDNA ReplicationGenetic Predisposition to DiseaseGenotypeHaploidyHomozygoteMutationPlasmidsSaccharomyces cerevisiae

Identifiers

PMID12807766
PMCPMC1462586
OpenAlexW2107195780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.